Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients in Japan and the United States...
Cancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without cancer.1 The ground-breaking RESILIENCE project aims to prevent heart failure in patients who need anthracyclines to treat their cancer...
Rapid Detection of Modern Blood Thinners Could Reduce Preventable Complications in US Hospitals...
Healthcare localization and standardization support the Belt and Road Initiative...
Voom™ Medical Devices launches the distinctive patented Revcon™ Anchor v2.0 screw, the only neutral non-compressive dual-zone pitched single screw solution for minimally invasive bunion surgery, exclusively used with the Bunionplasty® procedure....
GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size....
Sensor can potentially provide an easy, low-cost alternative to expensive footwear modifications...
Nearly 50% of American adults living with diabetes will be affected by diabetic neuropathy complications in their lifetime...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the launch and national availability of its ATN Profile, a blood-based test that combines three, well-researched blood biomarkers to identify and assess biological changes associated with Alzheimer's disease – amyloid plaques, tau tangles and neurodegeneration (ATN) – which can help accelerate the path to diagnosis and intervention.i The test is available through physicians for use with patients ...
Brainomix Awarded Innovate UK Grant to Collaborate with Swiss-based Nanoflex Robotics...
